Business

March 19, 2014 10:50 AM

Scynexis eyes $68 million IPO

Durham drug-development company Scynexis hopes to raise up to $68.1 million with an initial public offering of stock.

Related content

Suggested for you

Comments

Videos

Today's Market

Nasdaq
Powered by Barchart

Editor's Choice Videos

Raleigh Top Jobs

View All Top Jobs